Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugues Talbot

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Nature Medicine|July 24, 2023
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trialFernanda Mosele, Elise Deluche, Amelie Lusque, et al.
Radiology|November 26, 2024
Liquid Biopsy versus CT: Comparison of Tumor Burden Quantification in 1065 Patients with MetastasesLama Dawi, Younes Belkouchi, Littisha Lawrance, et al.
Nature Medicine|September 4, 2025
Patritumab deruxtecan in HR<sup>+</sup>HER2<sup>-</sup> advanced breast cancer: a phase 2 trialBarbara Pistilli, Fernanda Mosele, Noemie Corcos, et al.
Cancer Cell|April 18, 2026
Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 studyDavid Planchard, Nathalie Cozic, Maria Fernanda Mosele, et al.
Nature Communications|January 28, 2021
Integrating deep learning CT-scan model, biological and clinical variables to predict severity of COVID-19 patientsNathalie Lassau, Samy Ammari, Emilie Chouzenoux, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Nature Medicine|July 24, 2023
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trialFernanda Mosele, Elise Deluche, Amelie Lusque, et al.
Radiology|November 26, 2024
Liquid Biopsy versus CT: Comparison of Tumor Burden Quantification in 1065 Patients with MetastasesLama Dawi, Younes Belkouchi, Littisha Lawrance, et al.
Nature Medicine|September 4, 2025
Patritumab deruxtecan in HR<sup>+</sup>HER2<sup>-</sup> advanced breast cancer: a phase 2 trialBarbara Pistilli, Fernanda Mosele, Noemie Corcos, et al.
Cancer Cell|April 18, 2026
Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 studyDavid Planchard, Nathalie Cozic, Maria Fernanda Mosele, et al.
Nature Communications|January 28, 2021
Integrating deep learning CT-scan model, biological and clinical variables to predict severity of COVID-19 patientsNathalie Lassau, Samy Ammari, Emilie Chouzenoux, et al.
Pageof 5